Co-Diagnostics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CODX Nasdaq 3840 co-dx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Co-Diagnostics, Inc.

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025 - Jul 15th, 2025 7:30 am
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - May 14th, 2025 7:30 am
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - May 9th, 2025 1:41 am
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - May 8th, 2025 2:01 pm
Concentra Group (CON) Tops Q1 Earnings and Revenue Estimates - May 7th, 2025 5:35 pm
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - Apr 29th, 2025 5:30 am
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Apr 2nd, 2025 10:00 am
Co-Diagnostics Full Year 2024 Earnings: Misses Expectations - Mar 29th, 2025 7:18 am
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Mar 28th, 2025 1:03 am
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - Mar 27th, 2025 2:01 pm
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - Mar 13th, 2025 7:30 am
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates - Mar 12th, 2025 3:25 pm
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit - Mar 6th, 2025 1:30 pm
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - Mar 3rd, 2025 7:30 am
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Feb 24th, 2025 6:18 am
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - Feb 21st, 2025 2:00 pm
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill - Jan 30th, 2025 7:30 am
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - Jan 7th, 2025 7:30 am
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Dec 10th, 2024 7:30 am
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations - Nov 10th, 2024 5:30 am